Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Supreme Court Of India
2002 Gujarat Riots
Enforcement Directorate (ED)
Maharashtra Government
University Grants Commission
Alt News
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Biological E's Corbevax vaccine approved for children aged 12-18 years
India

Biological E's Corbevax vaccine approved for children aged 12-18 years

Biological E's Corbevax vaccine approved for children aged 12-18 years
Written by Sagar
Feb 21, 2022, 07:23 pm 2 min read
Biological E's Corbevax vaccine approved for children aged 12-18 years
Corbevax has become the second COVID-19 vaccine approved for use in children and teenagers in India.

The Drugs Controller General of India (DCGI) has granted an emergency use authorization (EUA) to Corbevax—a COVID-19 vaccine developed by Hyderabad-based Biological E—for use in children aged between 12 and 18 years. The development comes nearly a week after a subject expert committee of the Central Drug Standard Control Organisation (CDSCO) recommended the vaccine for use in adolescents.

Context
Why does this story matter?
  • The approval makes Corbevax the second coronavirus vaccine to be available for the below-18 age group in India.
  • So far, India has been administering Bharat Biotech-developed COVAXIN to the population aged 15-18 years.
  • The country had started inoculation for that cohort from January 3. Since then, more than 7.6 crore children have been vaccinated against COVID-19.
Quote
Biological E issues statement on approval

"BE received the approval for restricted use in an emergency situation in adolescents aged 12 to 18 years based on interim results (of the ongoing phase II/III clinical study)," Biological E said in a statement on Monday.

Details
A brief about Corbevax

Corbevax is touted as India's first indigenous receptor-binding domain (RBD) protein subunit vaccine against the coronavirus SARS-CoV-2. It had already been approved for restricted use in an emergency situation for adults. That nod had come from the DCGI in December 2021. In August last year, the central government had placed an order for 30 crore doses of Corbevax.

Information
Corbevax Stored at 2-8°C

Corbevax is administered through the intramuscular route with two doses scheduled 28 days apart. It is stored at temperatures ranging from 2-8°C. It comes in 0.5 ml, 5 ml, and 10 ml vial packs, Biological E said.

Statement
'Closer to finishing our global fight'

"We are pleased with this significant development, which helps extend the reach of our vaccine to the age group of 12 to 18 years in our country," Biological E's Managing Director Mahima Datla said in a statement. "We truly believe that with this approval, we are even closer to finishing our global fight against the COVID-19 pandemic." Datla added.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
Drugs Controller General of India
COVID-19
Corbevax
Related
Latest
West Indies hammer Bangladesh in second T20I: Key stats
West Indies hammer Bangladesh in second T20I: Key stats Sports
Himachal: 16 killed after bus falls into gorge in Kullu
Himachal: 16 killed after bus falls into gorge in Kullu India
How to redeem Free Fire MAX codes for July 4
How to redeem Free Fire MAX codes for July 4 Technology
Karnataka's Sini Shetty is Femina Miss India World 2022!
Karnataka's Sini Shetty is Femina Miss India World 2022! Entertainment
5 iconic accommodations in Paris
5 iconic accommodations in Paris Lifestyle
Drugs Controller General of India
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
New anti-COVID drug may cost up to Rs. 3,000: Report
New anti-COVID drug may cost up to Rs. 3,000: Report India
J&J vaccine's 1cr doses ready for export after CDL nod
J&J vaccine's 1cr doses ready for export after CDL nod India
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
More News
COVID-19
COVID-19: India logs 16,103 fresh cases, 31 more fatalities
COVID-19: India logs 16,103 fresh cases, 31 more fatalities India
BJP to pass '2024 polls' resolution in national executive meeting
BJP to pass '2024 polls' resolution in national executive meeting Politics
Odisha: Full Jagannath Rath Yatra opens today after two years
Odisha: Full Jagannath Rath Yatra opens today after two years India
5 reasons you must have kadha every day
5 reasons you must have kadha every day Lifestyle
How to make the best of work from home
How to make the best of work from home Lifestyle
More News
Corbevax
COVID-19 vaccination for 12-14 years begins; here's how to register
COVID-19 vaccination for 12-14 years begins; here's how to register India
Phase 2/3 trials of Corbevax on 5-18 age group permitted
Phase 2/3 trials of Corbevax on 5-18 age group permitted India
More News
Related
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
India gets first nasal spray for COVID-19 treatment
India gets first nasal spray for COVID-19 treatment India
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022